Bristol Myers Squibb (BMS) provides year-round corporate grants and independent medical education (IME) support—focusing on health equity initiatives and priority oncology/hematology areas—to advance patient care, remove barriers to treatment, and improve outcomes for diverse and underserved populations.
Eligibility Criteria:
-
Health Equity Initiatives (U.S. only):
-
Non-profit or academic organizations working in disease awareness & education, access to quality care, patient support services, or health-equity policy and advocacy within BMS therapeutic areas.
-
-
Oncology & Hematology Grants/IME:
-
Open for both IME and other grants: Bladder cancer, Biomarker research, Colorectal cancer, Lung cancer, Esophageal/Gastric cancers, Liver (HCC), Melanoma, Renal cell carcinoma, Acute myeloid leukemia, Chronic lymphocytic leukemia, Hodgkin’s lymphoma, Multiple myeloma, Myelodysplastic syndrome, Non-Hodgkin’s lymphoma.
-
Open for grants only (not IME): Breast cancer, Pancreatic cancer, Glioblastoma (GBM), Head & neck cancer, Prostate cancer, Anemia/beta thalassemia, Chronic myeloid leukemia, Myelofibrosis.
-
Funding Details:
-
Independent Medical Education (IME): Accredited educational activities for healthcare professionals in eligible disease areas.
-
Corporate Grants & Sponsorships: Support for program development, educational materials, conference participation, patient-focused initiatives, community outreach, and advocacy projects.
-
Philanthropic Donations: Unrestricted gifts supporting humanitarian, science & education, culture & arts, and community & environment projects aligned with BMS’s philanthropic priorities.
Deadline:
-
Rolling Submissions: Applications accepted throughout the year.
-
Advance Notice: For conference support, submit at least 45 days before the event start; for other projects, allow at least 60 days before the proposed start date.
Where to Apply & Further Information:
Submit requests and view full guidelines on the BMS Funding Portal.